These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 6886479)

  • 1. Antibody response to pneumococcal vaccination in children younger than five years of age.
    Douglas RM; Paton JC; Duncan SJ; Hansman DJ
    J Infect Dis; 1983 Jul; 148(1):131-7. PubMed ID: 6886479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of an alternative reduced-dose infant schedule and a second year catch-up schedule with 7-valent pneumococcal conjugate vaccine on pneumococcal carriage: a randomized controlled trial.
    Dagan R; Givon-Lavi N; Porat N; Greenberg D
    Vaccine; 2012 Jul; 30(34):5132-40. PubMed ID: 22683519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pneumococcal conjugate vaccine primes for polysaccharide-inducible IgG2 antibody response in children with recurrent otitis media acuta.
    Breukels MA; Rijkers GT; Voorhorst-Ogink MM; Zegers BJ; Sanders LA
    J Infect Dis; 1999 May; 179(5):1152-6. PubMed ID: 10191217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preimmunization and postimmunization pneumococcal antibody titers in children with recurrent infections.
    Hidalgo H; Moore C; Leiva LE; Sorensen RU
    Ann Allergy Asthma Immunol; 1996 Apr; 76(4):341-6. PubMed ID: 8612116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of age on the response to Streptococcus pneumoniae vaccine in patients with recurrent infections and normal immunoglobulin concentrations.
    Sorensen RU; Leiva LE; Javier FC; Sacerdote DM; Bradford N; Butler B; Giangrosso PA; Moore C
    J Allergy Clin Immunol; 1998 Aug; 102(2):215-21. PubMed ID: 9723664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity of 13-valent pneumococcal conjugate vaccine among children with underlying medical conditions.
    Jallow S; Madhi SA; Madimabe R; Sipambo N; Violari A; Kala U; Petersen K; Naidoo S; Verwey C; Moore DP; Nunes MC
    Vaccine; 2017 Aug; 35(34):4321-4329. PubMed ID: 28688781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody response to pneumococcal capsular polysaccharide vaccine in the elderly.
    Sankilampi U; Honkanen PO; Bloigu A; Herva E; Leinonen M
    J Infect Dis; 1996 Feb; 173(2):387-93. PubMed ID: 8568300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pneumococcal revaccination of splenectomized children.
    Konradsen HB; Pedersen FK; Henrichsen J
    Pediatr Infect Dis J; 1990 Apr; 9(4):258-63. PubMed ID: 2336311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of immunologic memory following primary vaccination with the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine in infants.
    Knuf M; Pankow-Culot H; Grunert D; Rapp M; Panzer F; Köllges R; Fanic A; Habib A; Borys D; Dieussaert I; Schuerman L
    Pediatr Infect Dis J; 2012 Jan; 31(1):e31-6. PubMed ID: 21909049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of the 23-valent pneumococcal polysaccharide vaccine in Alaska Native chronic alcoholics compared with nonalcoholic Native and non-Native controls.
    McMahon BJ; Parkinson AJ; Bulkow L; Davidson M; Wainwright K; Wolfe P; Schiffman GS
    Am J Med; 1993 Dec; 95(6):589-94. PubMed ID: 8259775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticapsular serum antibody concentration and protection against pneumococcal colonization among children vaccinated with 7-valent pneumococcal conjugate vaccine.
    Millar EV; O'Brien KL; Bronsdon MA; Madore D; Hackell JG; Reid R; Santosham M
    Clin Infect Dis; 2007 May; 44(9):1173-9. PubMed ID: 17407035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody response to pneumococcal capsular polysaccharide vaccine in African children.
    Temple K; Greenwood B; Inskip H; Hall A; Koskela M; Leinonen M
    Pediatr Infect Dis J; 1991 May; 10(5):386-90. PubMed ID: 2067888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines.
    Wysocki J; Tejedor JC; Grunert D; Konior R; Garcia-Sicilia J; Knuf M; Bernard L; Dieussaert I; Schuerman L
    Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S77-88. PubMed ID: 19325450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antibody response after immunization with pneumococcal polysaccharide vaccine in splenectomized mice: the effect of re-immunization with pneumococcal antigens.
    Aaberge IS; Løvik M
    APMIS; 1996 Apr; 104(4):307-17. PubMed ID: 8645471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumococcal conjugate vaccine-elicited antibody persistence and immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in children previously vaccinated with 4 doses of either 7-valent or 13-valent pneumococcal conjugate vaccine.
    Quinet B; Laudat F; Gurtman A; Patterson S; Sidhu M; Gruber WC; Scott DA
    Pediatr Infect Dis J; 2014 Oct; 33(10):1065-76. PubMed ID: 25093973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine.
    Vesikari T; Wysocki J; Chevallier B; Karvonen A; Czajka H; Arsène JP; Lommel P; Dieussaert I; Schuerman L
    Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S66-76. PubMed ID: 19325449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of 13-valent pneumococcal conjugate vaccine administered according to 4 different primary immunization schedules in infants: a randomized clinical trial.
    Spijkerman J; Veenhoven RH; Wijmenga-Monsuur AJ; Elberse KE; van Gageldonk PG; Knol MJ; de Melker HE; Sanders EA; Schouls LM; Berbers GA
    JAMA; 2013 Sep; 310(9):930-7. PubMed ID: 24002279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First and second dose antibody responses to pneumococcal polysaccharide vaccine in infants.
    Koskela M; Leinonen M; Häivä VM; Timonen M; Mäkelä PH
    Pediatr Infect Dis; 1986; 5(1):45-50. PubMed ID: 3945575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamics and Determinants of Pneumococcal Antibodies Specific against 13 Vaccine Serotypes in the Pre-Vaccination Era.
    Prins-van Ginkel AC; Berbers GA; Grundeken LH; Tcherniaeva I; Wittenberns JI; Elberse K; Mollema L; de Melker HE; Knol MJ
    PLoS One; 2016; 11(1):e0147437. PubMed ID: 26796783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody response to 14-valent pneumococcal capsular polysaccharide vaccine in pre-school age children.
    Leinonen M; Säkkinen A; Kalliokoski R; Luotonen J; Timonen M; Mäkelä PH
    Pediatr Infect Dis; 1986; 5(1):39-44. PubMed ID: 3945574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.